Carlos M. De Castro, III, M.D.

Carlos M. De Castro is a professor in Medicine at Duke University Medical Center, Durham, NC.  He received his MD degree at the University of Texas Southwestern Medical School in Dallas, TX in 1985.  He completed his residency training in internal medicine at Parkland Memorial Hospital, Dallas, TX, and his fellowship in hematology and oncology at Duke University Medical Center.  He joined the faculty of Duke in 1991.  His clinical research clinical research: A type of research that involves individual persons or a group of people. There are three types of clinical research. Patient-oriented research includes clinical trials which test how a drug, medical device, or treatment approach works in people. Epidemiology or behavioral studies look at the… is focused on the care of patients with hematological malignancies including acute and chronic leukemias, lymphomas, multiple myeloma.  He is especially interested in bone marrow failure bone marrow failure: A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH). Bone marrow failure can be acquired (begin any time in life) or can be… syndromes including myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone marrow does not work well, and the bone marrow cells fail to make enough healthy blood cells. Myelo refers to the bone marrow. Dysplastic means abnormal growth or development. People with MDS have low blood cell count for at… , and paroxysmal nocturnal hemoglobiniuria. In addition to having served as the medical director for the apheresis unit, the outpatient chemotherapy chemotherapy: (kee-moe-THER-uh-pee) The use of medicines that kill cells (cytotoxic agents). People with high-risk or intermediate-2 risk myelodysplastic syndrome (MDS) may be given chemotherapy to kill bone marrow cells that have an abnormal size, shape, or look. Chemotherapy hurts healthy cells along with… treatment center, the 9100 oncology ward, he is currently the Hematology-Oncology Fellowship Program Director.